PRP2 inhibitors represent a chemical class that specifically targets the PRP2 protein, which is a critical component of the spliceosome, a macromolecular complex involved in pre-mRNA splicing. PRP2, also known as DHX16, is an ATP-dependent RNA helicase that facilitates the structural rearrangements required for the second step of splicing, where exons are joined together and introns are removed. The inhibition of PRP2 disrupts its function in this highly coordinated process, potentially leading to altered or incomplete splicing events. In particular, PRP2's activity depends on its ability to hydrolyze ATP to provide the necessary energy for helicase activity, which allows the unwinding and remodeling of RNA-protein complexes. Compounds classified as PRP2 inhibitors typically interact with this protein by either blocking ATP binding or by interfering with its helicase function, ultimately modulating RNA processing at the molecular level.
The detailed mechanism of PRP2 inhibition often involves the stabilization of specific conformations of the spliceosome or the prevention of required transitions between different structural states during the splicing cycle. These inhibitors are frequently small molecules designed to target the ATPase domain or interact with key residues involved in RNA binding. Structural studies, often involving X-ray crystallography or cryo-electron microscopy, have been used to map the interaction sites between PRP2 and its inhibitors. Such interactions can result in the stalling of spliceosome assembly or improper coordination of splicing intermediates, leading to the failure of pre-mRNA to undergo accurate splicing. As PRP2 is part of a complex network of helicases and splicing factors, inhibitors of this protein can provide valuable insights into RNA-protein interactions and the energy-dependent dynamics of spliceosome assembly and disassembly. These compounds serve as molecular probes that deepen our understanding of RNA splicing fidelity and regulation at a structural and biochemical level.
SEE ALSO...
Items 1 to 10 of 12 total
Display:
Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
---|---|---|---|---|---|---|
Brefeldin A | 20350-15-6 | sc-200861C sc-200861 sc-200861A sc-200861B | 1 mg 5 mg 25 mg 100 mg | $30.00 $52.00 $122.00 $367.00 | 25 | |
Inhibits protein transport from the endoplasmic reticulum to the Golgi apparatus, potentially affecting TMEM171 trafficking. | ||||||
Monensin A | 17090-79-8 | sc-362032 sc-362032A | 5 mg 25 mg | $152.00 $515.00 | ||
A polyether antibiotic that alters intracellular transport, possibly impacting TMEM171's localization or function. | ||||||
Tunicamycin | 11089-65-9 | sc-3506A sc-3506 | 5 mg 10 mg | $169.00 $299.00 | 66 | |
Inhibits N-linked glycosylation, which could affect the folding and function of glycosylated transmembrane proteins like TMEM171. | ||||||
MG-132 [Z-Leu- Leu-Leu-CHO] | 133407-82-6 | sc-201270 sc-201270A sc-201270B | 5 mg 25 mg 100 mg | $56.00 $260.00 $980.00 | 163 | |
A proteasome inhibitor, potentially affecting the degradation of TMEM171 and thus its cellular levels. | ||||||
Cycloheximide | 66-81-9 | sc-3508B sc-3508 sc-3508A | 100 mg 1 g 5 g | $40.00 $82.00 $256.00 | 127 | |
Inhibits eukaryotic protein synthesis, potentially reducing TMEM171 expression by limiting protein translation. | ||||||
Chloroquine | 54-05-7 | sc-507304 | 250 mg | $68.00 | 2 | |
Affects lysosomal function, which could influence the degradation pathways of transmembrane proteins like TMEM171. | ||||||
GW4869 | 6823-69-4 | sc-218578 sc-218578A | 5 mg 25 mg | $199.00 $599.00 | 24 | |
Inhibits exosome release, potentially affecting the cellular processes TMEM171 is involved in if it plays a role in exosome formation or function. | ||||||
2-Deoxy-D-glucose | 154-17-6 | sc-202010 sc-202010A | 1 g 5 g | $65.00 $210.00 | 26 | |
A glucose analog that inhibits glycolysis, potentially affecting energy-dependent processes involved in TMEM171's function. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $62.00 $155.00 $320.00 | 233 | |
An mTOR inhibitor that can affect cell growth and differentiation, potentially impacting TMEM171 expression. | ||||||
Filipin III | 480-49-9 | sc-205323 sc-205323A | 500 µg 1 mg | $116.00 $145.00 | 26 | |
A polyene macrolide that binds to cholesterol, potentially disrupting lipid rafts and affecting transmembrane protein function. |